Patents by Inventor Jerry D. Childers

Jerry D. Childers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of signalling a patient during buccal agent delivery
    Patent number: 5053032
    Abstract: An osmotic device for delivering a beneficial drug, such as an anti-fungal, into the mouth of a human patient is disclosed. The device has a size and shape adapting it to be comfortably retained in the mouth for extended periods of time. The device comprises a wall surrounding a compartment housing a layer of an agent that is insoluble to very soluble in aqueous biological fluids, e.g., saliva, and a layer of a fluid swellable, hydrophilic polymer. A passageway in the wall connects the agent with the exterior of the device. The wall is permeable to the passage of aqueous biological fluid but substantially impermeable to the passage of the hydrophilic polymer. In one embodiment the beneficial agent has a different color than the hydrophilic polymer. The wall is sufficiently translucent to permit the patient to see the amount of drug/beneficial agent remaining to be delivered.
    Type: Grant
    Filed: December 21, 1990
    Date of Patent: October 1, 1991
    Inventors: Brian L. Barclay, Jerry D. Childers, Jeri Wright, Virgil A. Place, Patrick S. L. Wong
  • Method for administering nilvadipine for treating cardiovascular symptoms
    Patent number: 5028434
    Abstract: A dosage form is disclosed comprising nilvadipine for administering to a patient in need of cardiovascular therapy.
    Type: Grant
    Filed: August 7, 1989
    Date of Patent: July 2, 1991
    Assignee: Alza Corporation
    Inventors: Brian L. Barclay, Patrick S. Wong, Jeri D. Wright, Jerry D. Childers
  • Oral osmotic device with hydrogel driving member
    Patent number: 5021053
    Abstract: An osmotic device for delivering a beneficial drug, such as an anti-fungal, into the mouth of a human patient is disclosed. The device has a size and shape adapting it to be comfortably retained in the mouth for extended periods of time. The device comprises a wall surrounding a compartment housing a layer of an agent that is insoluble to very soluble in aqueous biological fluid, e.g., saliva, and a layer of a fluid swellable, hydrophilic polymer. A passageway in the wall connects the agent with the exterior of the device. The wall is permeable to the passage of aqueous biological fluid but substantially impermeable to the passage of the hydrophilic polymer. In one embodiment the beneficial agent has a different color than the hydrophilic polymer. The wall is sufficiently translucent to permit the patient to see the amount of drug/beneficial agent remaining to be delivered.
    Type: Grant
    Filed: July 14, 1989
    Date of Patent: June 4, 1991
    Assignee: Alza Corporation
    Inventors: Brian L. Barclay, Jerry D. Childers, Jeri Wright, Virgil A. Place, Patrick S. L. Wong
  • Osmotic dosage form comprising an estrogen and a progestogen
    Patent number: 4948593
    Abstract: An osmotic device is disclosed comprising an estrogenic and a progestogenic steroid that are delivered as a contraceptive pair for fertility regulation in a female.
    Type: Grant
    Filed: May 15, 1989
    Date of Patent: August 14, 1990
    Assignee: Alza Corporation
    Inventors: Jeri D. Wright, Jerry D. Childers, Brian L. Barcley, Patrick S. L. Wong, Linda E. Atkinson
  • Dosage form for administering nilvadipine for treating cardiovascular symptoms
    Patent number: 4902514
    Abstract: A dosage form is disclosed comprising nilvadipine for administering to a patient in need of cardiovascular therapy.
    Type: Grant
    Filed: July 21, 1988
    Date of Patent: February 20, 1990
    Assignee: ALZA Corporation
    Inventors: Brian L. Barclay, Patrick S. L. Wong, Jeri D. Wright, Jerry D. Childers